RIGEL PHARMACEUTICALS INC — Director's Dealing 2018

Aug 22, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RIGEL PHARMACEUTICALS INC (RIGL)
CIK: 0001034842
Period of Report: 2018-08-17

Reporting Person: RODRIGUEZ RAUL R (Director, CEO, President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-08-17	Common Stock	P	114000	$2.6316	Acquired	173519	Direct

Footnotes

F1: The price reported in Column 4 is the weighted average price. These shares were purchased in multiple transactions ranging from $2.61 to $2.64. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the issuer, or the Securities and Exchange Commission, full information regarding the shares purchased at each such separate price.

F2: Includes 2,502 shares that were purchased by the Reporting Person on June 29, 2018 under the Issuer's Employee Stock Purchase Plan.